Diagnosis and treatment of glucocorticoid-induced osteoporosis.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 10199058.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glucocorticoids are a mainstay in the treatment of many diseases, including pulmonary and rheumatologic disorders. Unfortunately, as many as 90% of long-term glucocorticoid recipients lose a significant amount of bone and incur an increased risk of fractures. This paper reviews the pathophysiology, diagnosis, and treatment of glucocorticoid-induced osteoporosis.